Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose

Clinical Nuclear Medicine

Volumn 24, Issue 8, 1999, Pages 597-600

  Alibazoglu, Haluk ^a   Alibazoglu, Buket ^a   Hollinger, Edward F ^a   Ingram, Sharyn A ^a   Willoughby, William A ^a   Lamonica, Gregory ^a   Ali, Amjad ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

FDG PET; I 131 therapy; Thymus

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; THYROGLOBULIN;

ADULT; ARTICLE; CASE REPORT; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; RECURRENT CANCER; THYMUS; THYROID FOLLICULAR CARCINOMA; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; THYMUS GLAND; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032783091     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199908000-00011     Document Type: Article

References (15)

1. Patel PM, Alibazoglu H, Ali A, et al: Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 21:772, 1996.
2. Kubota K, Yamada S, Kondo T, et al: PET imaging of primary mediastinal tumours. Br J Cancer 73:882, 1996.
3. Liu RS, Yeh SH, Huang MH, et al: Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report. Eur J Nucl Med 22:1402, 1995.
4. Uematsu H, Sadato N, Ohtsubo T, et al: Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 39:453, 1998.
5. Grunwald F, Menzel C, Bender H, et al: Comparison of 18-FDG-PET with 131-iodine and 99m-Tc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 7:327, 1997.
6. Fridrich L, Messa C, Landoni C, et al: Whole-body scintigraphy with 99m-Tc-MIBI, 18F-FDG and 131-I in patients with metastatic thyroid carcinoma. Nucl Med Commun 18:3, 1997.
7. Grunwald F, Schomburg A, Bender H, et al: Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 23:312, 1996.
8. Joensuu H, Ahonen A: Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. J Nucl Med 28:910, 1987.
9. Vermiglio F, Baudin E, Travagli JP, et al: Iodine concentration by the thymus in thyroid carcinoma. J Nucl Med 37:1830, 1996.
10. Bestagno M, Pagliaini R, Maira G, et al: Mediastinal uptake of 131-I in patients with thyroid cancer: May it be referred to normal thymus? Eur J Nucl Med 20:648, 1993.
11. Veronikis IE, Simkin P, Braverman LE: Thymic uptake of iodine-131 in the anterior mediastinum. J Nucl Med 37:991, 1996.
12. Dzhemukhadze GK, Volkova MS, Tongur AM, et al: Radiation sensitivity of membrane-bound glucose-6-phosphatase. Radiobiologiia 25:603, 1985.
13. Som P, Atkins HL, Bandoypadhyay D, et al: A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose[18F]: Nontoxic tracer for rapid tumor detection. J Nucl Med 21:670, 1980.
14. Gallagher BM, Fowler JS, Gutterson NI, et al: Metabolic trapping as a principle of radiopharmaceutical design: Some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 19:1154, 1978.
15. Griffeth LK, Dehdashti F, McGuire AH, et al: PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 182:185, 1992.